Is LPAR5 agonist a new treatment for microvilli inclusion disease?
Am J Physiol Gastrointest Liver Physiol
.
2024 Nov 26.
doi: 10.1152/ajpgi.00355.2024.
Online ahead of print.
Author
C Chris Yun
1
2
Affiliations
1
Division of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
2
Gastroenterology Research, Atlanta Veterans Administration Medical Center, Decatur, GA, USA.
PMID:
39589437
DOI:
10.1152/ajpgi.00355.2024
No abstract available
Publication types
Editorial
Grants and funding
R01DK107719/HHS | National Institutes of Health (NIH)
I01BX004459/U.S. Department of Veterans Affairs (VA)